- Targeting world-first regulatory approval and commercialization of BNCT, a new type of cancer treatments
- Driving innovative medical technology development by open innovation across manufacturing industries and domestic academia
Our Portfolio
STELLA PHARMA CORPORATION
Outline | R&D, manufacturing and sales of medical products and medical devices |
---|---|
Website | |
Industry | Health/medicine |
Commercialization stage | Venture company |
Provided Support
Authorized Investment | 3.5 billion yen (maximum) |
---|---|
Announcement Date | Mar 24, 2016 |
Investment Structure |